Company / PP&E per Share
BioLife Solutions, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.30
FY2025
5-year range
$0.13 / $0.55
FY2021-FY2025
Trend
+133.2%
vs FY2024
Sector context
#115 of 133
Health Care
What the data says
BioLife Solutions, Inc.'s pp&e per share of $0.30 is lower than 86% of companies in the Health Care sector (FY2025). PP&E per Share returned to growth in FY2025 after 2 years of decline, reaching $0.30.
Based on SEC 10-K filings.
0.30 in FY2025 with a 5-year CAGR of -4.0%.
Improved from $0.13 to $0.30 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -18.0%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 133This company $0.30 Sector average $11.64
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 133.2% year-over-year.
- Ranks #115 out of 133 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2022.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.30 | +133.2% |
| FY2024 | $0.13 | -0.3% |
| FY2023 | $0.13 | -76.3% |
| FY2022 | $0.55 | +19.7% |
| FY2021 | $0.46 | +23.7% |
| FY2020 | $0.37 | +29.4% |
| FY2019 | $0.29 | +285.7% |
| FY2018 | $0.07 | -13.7% |
| FY2017 | $0.09 | -9.9% |
| FY2016 | $0.10 | -20.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026